Meek David D.

CIK 00015553377 companiesWEST LAFAYETTE, IN

SEC Profile

Transactions

Companies

Filings

CIK

0001555337

Recent Transactions

50 trades

Sale
uniQure N.V.$QURE
Ordinary Shares
2025-06-20$14.45/sh−2,112→ 34,190 total
Award
Cullinan Therapeutics, Inc.$CGEM
Stock Option (Right to Buy)
2025-06-12+38,513→ 38,513 total
Award
uniQure N.V.$QURE
Ordinary Shares
2025-06-11+7,970→ 36,302 total
Award
uniQure N.V.$QURE
Stock Option (Right to Buy)
2025-06-11+15,630→ 15,630 total
Award
uniQure N.V.$QURE
Ordinary Shares
2024-06-19+8,080→ 28,332 total
Award
uniQure N.V.$QURE
Stock Option (Right to Buy)
2024-06-19+15,840→ 15,840 total
Sale
uniQure N.V.$QURE
Ordinary Shares
2024-06-13$5.12/sh−2,229→ 20,252 total
Disposition to Issuer
Fusion Pharmaceuticals Inc.
Stock Option (Right to Buy)
2024-06-04−34,000→ 0 total
Award
Cullinan Therapeutics, Inc.$CGEM
Stock Option (Right to Buy)
2024-05-15+15,618→ 15,618 total
Award
Fusion Pharmaceuticals Inc.
Stock Option (Right to Buy)
2023-10-16+34,000→ 34,000 total
Sale
uniQure N.V.$QURE
Ordinary Shares
2023-06-16$18.85/sh−2,290→ 22,481 total
Award
uniQure N.V.$QURE
Stock Option (Right to Buy)
2023-06-13+17,060→ 17,060 total
Award
uniQure N.V.$QURE
Ordinary Shares
2023-06-13+8,700→ 24,771 total
Sale
uniQure N.V.$QURE
Ordinary Shares
2023-02-27$19.71/sh−389→ 16,071 total
Award
Mirati Therapeutics, Inc.
Common Stock
2023-01-20+89,379→ 151,171 total
Award
Mirati Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2023-01-20+151,233→ 151,233 total
Sale
Mirati Therapeutics, Inc.
Common Stock
2023-01-17$42.38/sh−3,179→ 61,792 total
Sale
Mirati Therapeutics, Inc.
Common Stock
2022-12-21$40.41/sh−4,616→ 64,971 total
Award
Mirati Therapeutics, Inc.
Common Stock
2022-12-19+35,425→ 69,587 total
Other
Entasis Therapeutics Holdings Inc.
Stock Option (right to buy)
2022-07-11−11,000→ 0 total
Other
Entasis Therapeutics Holdings Inc.
Stock Option (right to buy)
2022-07-11−17,307→ 0 total
Disposition to Issuer
Entasis Therapeutics Holdings Inc.
Common Stock
2022-07-11$2.20/sh−27,500→ 0 total
Disposition from Tender
Entasis Therapeutics Holdings Inc.
Common Stock
2022-07-07$2.20/sh−22,000→ 0 total
Award
uniQure N.V.$QURE
Stock Option (Right to Buy)
2022-06-15+17,810→ 17,810 total
Award
uniQure N.V.$QURE
Ordinary Shares
2022-06-15+9,080→ 16,460 total
Sale
uniQure N.V.$QURE
Ordinary Shares
2022-02-28$16.70/sh−602→ 7,380 total
Award
uniQure N.V.$QURE
Stock Option (Right to Buy)
2022-02-24+2,645→ 2,645 total
Award
uniQure N.V.$QURE
Ordinary Shares
2022-02-24+1,534→ 7,982 total
Award
Entasis Therapeutics Holdings Inc.
Common Stock
2022-01-18+27,500→ 49,500 total
Award
Mirati Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2022-01-14+56,433→ 56,433 total
Award
Mirati Therapeutics, Inc.
Common Stock
2022-01-14+34,057→ 34,057 total
Award
Mirati Therapeutics, Inc.
Non Qualified Stock Option (right to buy)
2021-09-22+150,300→ 150,300 total
Award
Entasis Therapeutics Holdings Inc.
Stock Option (Right to Buy)
2021-07-16+5,769→ 5,769 total
Award
Entasis Therapeutics Holdings Inc.
Stock Option (Right to Buy)
2021-07-16+11,538→ 11,538 total
Disposition to Issuer
Entasis Therapeutics Holdings Inc.
Stock Option (Right to Buy)
2021-07-16−15,000→ 0 total
Disposition to Issuer
Entasis Therapeutics Holdings Inc.
Stock Option (Right to Buy)
2021-07-16−7,500→ 0 total
Award
Entasis Therapeutics Holdings Inc.
Common Stock
2021-04-01+22,000→ 22,000 total
Sale
uniQure N.V.$QURE
Ordinary Shares
2021-03-02$37.50/sh−505→ 6,448 total
Award
uniQure N.V.$QURE
Stock Option (Right to Buy)
2021-02-25+4,107→ 4,107 total
Award
uniQure N.V.$QURE
Ordinary Shares
2021-02-25+2,382→ 6,953 total
Award
Entasis Therapeutics Holdings Inc.
Stock Option (Right to Buy)
2020-06-10+11,000→ 11,000 total
Award
uniQure N.V.$QURE
Ordinary Shares
2020-02-27+2,063→ 4,571 total
Award
uniQure N.V.$QURE
Stock Option (Right to Buy)
2020-02-27+3,620→ 3,620 total
Sale
uniQure N.V.$QURE
Ordinary Shares
2020-01-28$60.94/sh−4→ 3,226 total
Sale
uniQure N.V.$QURE
Ordinary Shares
2020-01-28$62.20/sh−718→ 2,508 total
Award
Entasis Therapeutics Holdings Inc.
Stock Option (Right to Buy)
2019-06-19+7,500→ 7,500 total
Award
Entasis Therapeutics Holdings Inc.
Stock Option (Right to Buy)
2019-06-19+15,000→ 15,000 total
Award
uniQure N.V.$QURE
Stock Option (Right to Buy)
2019-01-25+5,295→ 5,295 total
Award
uniQure N.V.$QURE
Ordinary Shares
2019-01-25+3,230→ 3,230 total
Award
uniQure N.V.$QURE
Stock Option (Right to Buy)
2018-06-14+10,000→ 10,000 total

Meek David D.

Recent Transactions

Companies

Recent Filings

Address